STOCK TITAN

Phathom Pharmaceuticals to Participate at Upcoming Investor Healthcare Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Phathom Pharmaceuticals (Nasdaq: PHAT) announced its management team will participate in two virtual investor conferences in December 2020:

  • Evercore ISI 3rd Annual HealthCONx Conference
    Date: December 1, 2020
    Live Presentation Time: 10:55 am ET
  • Piper Sandler 32nd Annual Virtual Healthcare Conference
    Date: December 2, 2020
    Pre-recorded presentation available online

Additionally, one-on-one meetings will be held during these events. For access to the presentations, visit Phathom's website.

Positive
  • None.
Negative
  • None.

FLORHAM PARK, N.J., Nov. 27, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of the management team will participate at two upcoming virtual investor conferences in December, including:

  • Evercore ISI 3rd Annual HealthCONx Conference
    Date: December 1, 2020
    Live Presentation Time: 10:55 am ET
  • Piper Sandler 32nd Annual Virtual Healthcare Conference
    Date: December 2, 2020
    Pre-recorded presentation available online

Executive management will also participate in one-on-one meetings during the duration of the conferences.

To access the live webcast and archived recordings for each presentation, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. Recordings will be available for 30 days following each event.

About Phathom
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders. For more information about Phathom, visit the Company’s website at www.phathompharma.com or follow the Company on social media: LinkedIn at www.linkedin.com/company/phathompharma and Twitter @PhathomPharma.

CONTACTS

Media Contact:
Nick Benedetto
1-877-742-8466
media@phathompharma.com

Investor Contact:
Todd Branning
1-877-742-8466
ir@phathompharma.com


FAQ

What is the date of the Evercore ISI HealthCONx Conference for Phathom Pharmaceuticals?

The Evercore ISI 3rd Annual HealthCONx Conference is on December 1, 2020.

When will the Piper Sandler Healthcare Conference take place for Phathom Pharmaceuticals?

The Piper Sandler 32nd Annual Virtual Healthcare Conference is on December 2, 2020.

How can I access the presentations for Phathom Pharmaceuticals' investor conferences?

You can access the live presentations and archived recordings on Phathom's website under the News & Events section.

What is the stock symbol for Phathom Pharmaceuticals?

The stock symbol for Phathom Pharmaceuticals is PHAT.

Will Phathom Pharmaceuticals' management hold one-on-one meetings at the conferences?

Yes, the management will participate in one-on-one meetings during the conferences.

Phathom Pharmaceuticals, Inc.

NASDAQ:PHAT

PHAT Rankings

PHAT Latest News

PHAT Stock Data

555.22M
51.10M
7.73%
109.32%
20.55%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
FLORHAM PARK